UT Southwestern Medical Center will get up to $25 million from the Advanced Research Projects Agency for Health (ARPA-H) to create fully functional, patient-specific artificial livers that could ease the nation’s chronic organ shortage and reshape how liver disease is treated and studied.
The project brings together researchers across UT Southwestern, including Hao Zhu, M.D., Walter Akers, Ph.D., D.V.M., and Yasin Dhaher, Ph.D., supported by 11 core facilities and the institution’s hepatology clinics. Collaborators from Pennsylvania State University and the University of California, Davis, will contribute expertise in three-dimensional printing technology and GMP cell manufacturing.
